Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
2005 ◽
Vol 35
(11)
◽
pp. 639-644
◽
Keyword(s):
2014 ◽
Vol 88
(2)
◽
pp. 492
◽
Keyword(s):
2018 ◽
Vol 118
(4)
◽
pp. 627-636
◽
Keyword(s):
Keyword(s):
2000 ◽
Vol 8
(2)
◽
pp. 98-102
◽
2014 ◽
Vol 135
(1)
◽
pp. 103-108
◽
Keyword(s):
2014 ◽
Vol 1
(4)
◽
pp. 267-274
◽